FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3211226254> ?p ?o ?g. }

• W3211226254 endingPage "S955" @default.
• W3211226254 startingPage "S954" @default.
• W3211226254 abstract "Introduction: Cronkhite-Canada syndrome (CCS) is a rare, non-inherited condition associated with widespread gastrointestinal polyps, alopecia, onychodystrophy, skin hyperpigmentation, and diarrhea. It was first described in 1955 and has an estimated incidence of 1 case per million population. Here, we present a case of CCS manifested as widespread polyps throughout the gastrointestinal tract. Case Description/Methods: A 78-year-old female recently diagnosed with irritable bowel syndrome presented to Gastroenterology for a second opinion. Her complaints included 6 months of progressive abdominal pain, reflux, loss of taste, diarrhea (up to 10 episodes daily), intermittent bright red blood per rectum, and a 15kg weight loss. Physical exam revealed onychodystrophy but no alopecia or skin hyperpigmentation. Initial lab work showed low levels of potassium, albumin, and vitamin B6. Infectious stool studies were negative. Subsequent EGD showed multiple polypoid lesions in the stomach with sparing of the esophagus. Endoscopic ultrasound showed diffuse gastric wall thickening. Histopathological examination demonstrated hyperplastic polyps and no evidence of epithelial dysplasia or carcinoma. Colonoscopy revealed diffuse areas of altered vascular, congested, nodular mucosa with innumerous polypoid lesions of varying sizes throughout the entire colon. Histopathological examination showed inflammatory and adenomatous polyps with mildly active chronic colitis. Crohns disease was considered. Capsule endoscopy demonstrated multiple polyps throughout the entire small intestine. Given the clinical history and evidence of multiple polyps throughout the gastrointestinal tract, the patient was diagnosed with CCS. She was treated with a 6-week course of high dose prednisone followed by budesonide 9 mg daily (1 open capsule, 2 closed capsules) in conjunction with intermittent courses of rifaximin with complete resolution of her symptoms. A followup EGD and colonoscopy is planned in several months. Discussion: Due to its rarity, the etiology, pathophysiology, and optimal treatment of CCS is not well established. Diffuse polyposis and inflammation can lead to nutritional and electrolyte deficiencies as was seen in our patient’s case. Prior reports have found success in treatment with nutritional supplementation and immunosuppressive therapy, suggesting an underlying immune-mediated mechanism. Our patient had significant improvement in her symptoms with prednisone, budesonide and antibiotics.Figure 1" @default.
• W3211226254 created "2021-11-08" @default.
• W3211226254 creator A5025963888 @default.
• W3211226254 creator A5066191568 @default.
• W3211226254 creator A5070527656 @default.
• W3211226254 creator A5070602404 @default.
• W3211226254 date "2021-10-01" @default.
• W3211226254 modified "2023-10-16" @default.
• W3211226254 title "S2234 Cronkhite-Canada Syndrome Manifested as Diffuse Gastrointestinal Polyps" @default.
• W3211226254 doi "https://doi.org/10.14309/01.ajg.0000782468.28228.20" @default.
• W3211226254 hasPublicationYear "2021" @default.
• W3211226254 type Work @default.
• W3211226254 sameAs 3211226254 @default.
• W3211226254 citedByCount "0" @default.
• W3211226254 crossrefType "journal-article" @default.
• W3211226254 hasAuthorship W3211226254A5025963888 @default.
• W3211226254 hasAuthorship W3211226254A5066191568 @default.
• W3211226254 hasAuthorship W3211226254A5070527656 @default.
• W3211226254 hasAuthorship W3211226254A5070602404 @default.
• W3211226254 hasBestOaLocation W32112262541 @default.
• W3211226254 hasConcept C121608353 @default.
• W3211226254 hasConcept C126322002 @default.
• W3211226254 hasConcept C16005928 @default.
• W3211226254 hasConcept C2776728111 @default.
• W3211226254 hasConcept C2777333622 @default.
• W3211226254 hasConcept C2778435480 @default.
• W3211226254 hasConcept C2908781503 @default.
• W3211226254 hasConcept C526805850 @default.
• W3211226254 hasConcept C71924100 @default.
• W3211226254 hasConcept C90924648 @default.
• W3211226254 hasConceptScore W3211226254C121608353 @default.
• W3211226254 hasConceptScore W3211226254C126322002 @default.
• W3211226254 hasConceptScore W3211226254C16005928 @default.
• W3211226254 hasConceptScore W3211226254C2776728111 @default.
• W3211226254 hasConceptScore W3211226254C2777333622 @default.
• W3211226254 hasConceptScore W3211226254C2778435480 @default.
• W3211226254 hasConceptScore W3211226254C2908781503 @default.
• W3211226254 hasConceptScore W3211226254C526805850 @default.
• W3211226254 hasConceptScore W3211226254C71924100 @default.
• W3211226254 hasConceptScore W3211226254C90924648 @default.
• W3211226254 hasIssue "1" @default.
• W3211226254 hasLocation W32112262541 @default.
• W3211226254 hasLocation W32112262542 @default.
• W3211226254 hasOpenAccess W3211226254 @default.
• W3211226254 hasPrimaryLocation W32112262541 @default.
• W3211226254 hasRelatedWork W164697185 @default.
• W3211226254 hasRelatedWork W1681128304 @default.
• W3211226254 hasRelatedWork W1987896674 @default.
• W3211226254 hasRelatedWork W2064045866 @default.
• W3211226254 hasRelatedWork W2336812919 @default.
• W3211226254 hasRelatedWork W2735863358 @default.
• W3211226254 hasRelatedWork W2889840884 @default.
• W3211226254 hasRelatedWork W3028671835 @default.
• W3211226254 hasRelatedWork W3610906 @default.
• W3211226254 hasRelatedWork W4220913837 @default.
• W3211226254 hasVolume "116" @default.
• W3211226254 isParatext "false" @default.
• W3211226254 isRetracted "false" @default.
• W3211226254 magId "3211226254" @default.
• W3211226254 workType "article" @default.